Patients
at the center of everything we do
Toggle Navigation
Main Menu
MENU
MENU
Patients
Treating Cancer Smarter
How Molecular Profiling Works
What are Biomarkers?
Deciding How to Treat Metastatic Cancer
Sophisticated Laboratory Medicine
Can I order the test myself?
Your Treatment
I’ve been diagnosed with cancer. Now what?
Learn about your cancer
Find a Doctor
Questions for Your Doctor
Molecular Tumor Board
Financial Assistance
Working With Your Insurance
Patient Navigators
Patient Billing FAQ
Request Financial Assistance
Pay Your Bill
Physicians
Treating Cancer Smarter
What is precision oncology?
What are biomarkers?
Utilizing Artificial Intelligence (AI)
Molecular Tumor Board
Our Technology
DNA Sequencing
RNA Sequencing
Disease-Specific Testing
Reading Your Report
Clinical Trials
Just-in-Time (JIT) Services
Next-in-Line Services
Clinical Trial Navigators
Clinical Trials Connector
Join the Research Network
Financial Assistance
Patient Financial Burden
Insurance Coverage
Test Menu
Order A Test
All MI Profile Orders Include:
DNA Sequencing
RNA Sequencing
Biomarker Analysis by Tumor Type
Bladder
Breast
Cancer of Unknown Primary - Female
Cancer of Unknown Primary - Male
Cervical
Cholangiocarcinoma/Hepatobiliary
Colorectal and Small Intestinal
Endometrial
Esophageal Cancer
Gastric/GEJ
GIST
Glioma
Head & Neck
Kidney
Melanoma
Merkel Cell
Neuroendocrine/Small Cell Lung
Non-Small Cell Lung
Other Tumors
Ovarian
Pancreatic
Prostate
Salivary Gland
Sarcoma
Thyroid
Uterine Serous
Vulvar Cancer (SCC)
Click to Order
US (excludes New York)
New York
International
Molecular Profiling Technology
DNA Sequencing
Technical Specs
Mutations
Copy Number Alterations
Microsatellite Instability (MSI)
Tumor Mutational Burden (TMB)
Loss of Heterozygosity (LOH)
RNA Sequencing
Technical Specs
Fusions
Variant Transcripts
Artificial Intelligence
MI FOLFOXai™
MI GPSai™
Other
IHC
CISH
FISH
Research
Product Pipeline
RNA-Based Predictors
RNA Fusion Analysis
CarisDEAN: Deliberation Analytics
CarisADAPT: Biotargeting System
CarisNGP: Next Generation Profiling
Caris Research Institute
Biopharma
Drug Target Services
Clinical Trial Services
Caris CODEai
Just-In-Time Research
Molecular Testing Capabilities
Drug Target Discovery
Clinical Trials
Just-in-Time (JIT) Services
Next-in-Line Services
Clinical Trial Navigators
Clinical Trials Connector
Join the Research Network
Publications
POA
Precision Oncology Alliance
The brightest minds in oncology, cancer care, clinical research, and drug development
POA Leadership
Examine our Executive Committee and Tumor Group leaders
POA Members
Leading cancer centers around the world, committed to precision medicine
POA Publications
Advancing the understanding of molecular science and enabling the delivery of precision medicine
The Caris Precision Oncology Alliance™ is focused on collecting the latest scientific developments in genomics in order to help ensure the availability of individualized data to oncologists and patients and to further advance the integration of molecular profiling into all aspects of cancer care ."
- CHADI NABHAN, MD, MBA, FACP
Careers
Working at Caris
People with a passion for saving lives. Find out more.
Benefits
Learn how we take care of our employees.
Meet Our People
Amazing people sharing what it means to be a good team member
SEARCH JOBS
Want to join us? View current openings here
We exist to help relieve the suffering of as many people as possible."
- DAVID D. HALBERT, CHAIRMAN & CEO
About
Connect
Overview
News & Media
Webinars
Support
Contact
Leadership
Board of Directors
Management Team
Scientific Advisory Board
POA Leadership
Locations
Dallas Office (Headquarters)
Arizona Office / Labs
Denver Office
European Office (Basel)
Giving Back
Caris Foundation
ORDER
Order
MI Portal
International Distributors
Expertise
Caris Research Institute
Intellectual Property
MI PORTAL
Terms & Conditions
The terms and conditions for Caris Molecular Intelligence® tumor profiling by Caris Life Sciences®:
English
Arabic
Chinese
French
German
Portuguese
Russian
Spanish
Need Support?
Contact Us
or call
1.888.979.8669
(international: +41 21 533 53 00)
